nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Conjunctival hyperaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0807	0.0807	CcSEcCtD
Verteporfin—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0452	0.0452	CcSEcCtD
Verteporfin—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.039	0.039	CcSEcCtD
Verteporfin—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.0373	0.0373	CcSEcCtD
Verteporfin—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0373	0.0373	CcSEcCtD
Verteporfin—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0373	0.0373	CcSEcCtD
Verteporfin—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.0287	0.0287	CcSEcCtD
Verteporfin—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.0272	0.0272	CcSEcCtD
Verteporfin—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.0269	0.0269	CcSEcCtD
Verteporfin—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0258	0.0258	CcSEcCtD
Verteporfin—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0241	0.0241	CcSEcCtD
Verteporfin—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0227	0.0227	CcSEcCtD
Verteporfin—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.02	0.02	CcSEcCtD
Verteporfin—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0196	0.0196	CcSEcCtD
Verteporfin—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.0195	0.0195	CcSEcCtD
Verteporfin—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0193	0.0193	CcSEcCtD
Verteporfin—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.0179	0.0179	CcSEcCtD
Verteporfin—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0178	0.0178	CcSEcCtD
Verteporfin—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0177	0.0177	CcSEcCtD
Verteporfin—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.0177	0.0177	CcSEcCtD
Verteporfin—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0172	0.0172	CcSEcCtD
Verteporfin—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.0165	0.0165	CcSEcCtD
Verteporfin—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0162	0.0162	CcSEcCtD
Verteporfin—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.0155	0.0155	CcSEcCtD
Verteporfin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.0146	0.0146	CcSEcCtD
Verteporfin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0144	0.0144	CcSEcCtD
Verteporfin—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0143	0.0143	CcSEcCtD
Verteporfin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.014	0.014	CcSEcCtD
Verteporfin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.0139	CcSEcCtD
Verteporfin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.0135	0.0135	CcSEcCtD
Verteporfin—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.0134	0.0134	CcSEcCtD
Verteporfin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.0132	0.0132	CcSEcCtD
Verteporfin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.0132	0.0132	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0131	CcSEcCtD
Verteporfin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.013	0.013	CcSEcCtD
Verteporfin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0127	CcSEcCtD
Verteporfin—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0124	0.0124	CcSEcCtD
Verteporfin—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0123	CcSEcCtD
Verteporfin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.0122	0.0122	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0115	CcSEcCtD
Verteporfin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0113	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0109	CcSEcCtD
Verteporfin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0108	CcSEcCtD
Verteporfin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0108	CcSEcCtD
Verteporfin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0104	CcSEcCtD
Verteporfin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0101	CcSEcCtD
Verteporfin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.01	CcSEcCtD
Verteporfin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00932	0.00932	CcSEcCtD
Verteporfin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00908	0.00908	CcSEcCtD
Verteporfin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00895	0.00895	CcSEcCtD
Verteporfin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00837	0.00837	CcSEcCtD
Verteporfin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00798	0.00798	CcSEcCtD
Verteporfin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00797	0.00797	CcSEcCtD
Verteporfin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00793	0.00793	CcSEcCtD
Verteporfin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00752	0.00752	CcSEcCtD
